• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0702
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Cardiogenic Shock (2262)
Event Date 08/11/2021
Event Type  Death  
Manufacturer Narrative
The device was discarded and will not be returning.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Patient id: (b)(6).This is filed for atrial septal defect, requiring closure and cardiogenic shock, resulting in death.It was reported that this was a mitraclip procedure, performed on (b)(6) 2021, treating functional mitral regurgitation (mr) of grade 3.Two clips were implanted and the mr was reduced to grade 1+.One day post procedure, an atrial septal defect (asd) occluder was placed to close the hemodynamically relevant asd.The asd resolved on (b)(6) 2021.On (b)(6) 2021, the patient experienced cardiogenic shock, related to the asd, and a non-abbott ventricular assist device was placed for mechanical circulatory support.However, the patient died on (b)(6) 2021, of causes related to cardiogenic shock.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of atrial septal defect (asd), cardiogenic shock, and death are listed in the mitraclip g4 system instructions for use (ifu) as known possible complications associated with mitraclip procedures.Based on available information, the asd appears to be due to procedural conditions.The cardiogenic shock appears to be a cascading event of the asd.The death appears to be a cascading event of the cardiogenic shock.The reported hospitalization, use of a asd occluder, and ventricular assist device (vad) are the results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key12460637
MDR Text Key271050484
Report Number2024168-2021-08112
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/07/2022
Device Catalogue NumberSGC0702
Device Lot Number10206U414
Was Device Available for Evaluation? No
Date Manufacturer Received09/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
IMPLANTED MITRACLIPS (X2), IMPELLA; IMPLANTED MITRACLIPS (X2), IMPELLA
Patient Outcome(s) Death;
Patient Age69 YR
Patient Weight41
-
-